DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3q6n79/chr...

1. Research and Markets: Chronic Back Pain Pipeline Insights
Report 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets
(http://www.researchandmarkets.com/research/3q6n79/chronic_back)
has announced the addition of the "Chronic
Back Pain-Pipeline Insights" subscription to their offering.
This Chronic Back Pain-Pipeline Insights, report provides comprehensive
insights about pipeline drugs across this indication. A key objective of
the report is to establish the understanding for all the pipeline drugs
that fall under Chronic Back Pain.
This report provides information on the therapeutic development based on
the Chronic Back Pain dealing with all the pipeline drugs, comparative
analysis at various stages covering Filed, Phase III, Phase II, Phase I,
IND filed, Preclinical, Discovery and unknown stages, therapeutics
assessment by monotherapy and combination products and molecule type
drug information.
The report also covers the companies information involved in the
therapeutic development of the products. It also has highlighted the
discontinued and dormant products.
Key Topics Covered:

2. Chronic Back Pain Overview
Chronic Back Pain Pipeline Therapeutics
Chronic Back Pain Therapeutics under Development by Companies
Chronic Back Pain Late Stage Products (Filed and Phase III)
Comparative Analysis
Chronic Back Pain Mid Clinical Stage Products (Phase II)
Comparative Analysis
Chronic Back Pain Early Clinical Stage Products (Phase I and IND Filed)
Comparative Analysis
Chronic Back Pain Discovery and Pre-Clinical Stage Products
Comparative Analysis
Drug Candidate Profiles
Chronic Back Pain - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Chronic Back Pain - Discontinued Products
Chronic Back Pain - Dormant Products
Companies Involved in Therapeutics Development for Chronic Back Pain
Appendix
For more information visit http://www.researchandmarkets.com/research/3q6n79/chronic_back